FEED-Cystic Fibrosis (FEED-CF)

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorEmory University

About this trial

The goal of this study is to determine the extent to which excess dietary sugars serve as a precipitating factor in glucose intolerance in adults with cystic fibrosis (CF), a population at especially high risk for a unique form of diabetes (CF-related diabetes, CFRD) and with standard-of-care dietary recommendations (high-calorie, high-fat) that conflict with recommendations for other forms of diabetes.

This trial will investigate if the typical high-sugar, high-fat CF diet plays a role in diabetes risk and visceral fat accumulation in people with CF. A total of 30 participants will get a low-added sugar, high-fat diet and the other 30 will get a standard CF diet with no sugar restrictions. Participants will be randomized to the diet group they are assigned. All foods will be provided for 8 weeks.

Eligibility criteria

Qualifiers

Confirmed CF diagnosis

Ages 18 years and older

Baseline estimated daily total added sugar intake >16 tsp, as estimated from the Dietary Screener Questionnaire (DSQ).

Disqualifiers

Nocturnal tube feeds

BMI <18.5 kg/m2

Life expectancy < 12 months

Confirmed diagnosis of CFRD

Trial design

Treatments tested in this trial

  • Low-added sugar, high-fat diet
  • High-added sugar, high-fat CF diet

Treatment groups

60 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Emory University

Lead sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborator